Related Experiment Video
Updated: Aug 5, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Sequential stopping rules in clinical trials
1Department of Community Medicine, Oxford University, Radcliffe Infirmary.
Statistics in Medicine
|June 1, 1990
Summary
This review explores sequential analysis in medical trials, offering strategies for efficient clinical experimentation. It highlights methods to minimize sample sizes and address uncertainties in phase III trial design.
Area of Science:
- Medicine
- Biostatistics
- Clinical Trials
Background:
- Sequential analysis in clinical trials is crucial for efficient data interpretation.
- Phase III trials often involve genuine uncertainty and extensive clinical experimentation.
- Accurate estimation of treatment effects is vital for determining appropriate sample sizes.
Purpose of the Study:
- To review the development of sequential analysis in medical clinical trials.
- To propose practical and ethical strategies for advancing sequential analysis methods.
- To examine the impact of incorrect treatment effect estimates on sample size calculations.
Main Methods:
- Review of historical development of sequential analysis, including Armitage's contributions.
- Focus on group sequential procedures based on repeated significance tests.
- Analysis of pragmatic and ethical considerations in trial design under uncertainty.
Main Results:
- Sequential analysis offers strategies to progress clinical trial design.
- Group sequential methods can minimize expected sample sizes effectively.
- Understanding the consequences of incorrect effect estimates is key for robust trial design.
Conclusions:
- Simple strategies can enhance the development of sequential analysis in medicine.
- Group sequential procedures are valuable for efficient clinical experimentation.
- Addressing uncertainty and accurate sample size estimation are paramount in trial design.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:09Truncation in Survival Analysis
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are observed.
01:09Censoring Survival Data
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different reasons...